16
Participants
Start Date
August 31, 2010
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Temozolomide
Temozolomide 150 mg/m2/day PO Days 1-5 every 28 days
ABT-888
ABT-888 40 mg BID PO Days 1-7 every 28 days
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.
Collaborators (1)
Abbott
INDUSTRY
Georgetown University
OTHER